Your browser doesn't support javascript.
loading
The hybrid oncolytic peptide NTP-385 potently inhibits adherent cancer cells by targeting the nucleus.
Yin, Hao; Chen, Xi-Tong; Chi, Qiao-Na; Ma, Yan-Nan; Fu, Xing-Yan; Du, Shan-Shan; Qi, Yun-Kun; Wang, Ke-Wei.
Afiliação
  • Yin H; Department of Pharmacology, School of Pharmacy, Qingdao University Medical College, Qingdao University, #1 Ningde Road, Qingdao, 266073, China.
  • Chen XT; Institute of Innovative Drugs, Qingdao University, 38 Dengzhou Road, Qingdao, 266021, China.
  • Chi QN; Department of Medicinal Chemistry, School of Pharmacy, Qingdao University Medical College, Qingdao University, #1 Ningde Road, Qingdao, 266073, China.
  • Ma YN; College of Chemical Engineering, Qingdao University of Science and Technology, Qingdao, 266042, China.
  • Fu XY; Department of Medicinal Chemistry, School of Pharmacy, Qingdao University Medical College, Qingdao University, #1 Ningde Road, Qingdao, 266073, China.
  • Du SS; Department of Medicinal Chemistry, School of Pharmacy, Qingdao University Medical College, Qingdao University, #1 Ningde Road, Qingdao, 266073, China.
  • Qi YK; College of Chemical Engineering, Qingdao University of Science and Technology, Qingdao, 266042, China. shanshandu@qust.edu.cn.
  • Wang KW; Institute of Innovative Drugs, Qingdao University, 38 Dengzhou Road, Qingdao, 266021, China. qiyunkun@qdu.edu.cn.
Acta Pharmacol Sin ; 44(1): 201-210, 2023 Jan.
Article em En | MEDLINE | ID: mdl-35794372

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos / Melanoma Limite: Animals / Humans Idioma: En Revista: Acta Pharmacol Sin Assunto da revista: FARMACOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos / Melanoma Limite: Animals / Humans Idioma: En Revista: Acta Pharmacol Sin Assunto da revista: FARMACOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China